Blue Chip Partners, Inc. Bristol Myers Squibb CO Transaction History

Blue Chip Partners, Inc.

$1.15 Billion
Q3 2024

A detailed history of Blue Chip Partners, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Blue Chip Partners, Inc. holds 3,438 shares of BMY stock, worth $195,415. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,438

Previous 3,648 5.76%

Holding current value

$195,415

Previous $151,000 17.22%

% of portfolio

0.02%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$39.66 - $51.75 $8,328 - $10,867	-210 Reduced 5.76%	3,438 $177,000
Q2 2024 Jul 29, 2024	SELL	$40.25 - $52.99 $30,912 - $40,696	-768 Reduced 17.39%	3,648 $151,000
Q1 2024 Apr 25, 2024	BUY	$47.98 - $54.4 $94,760 - $107,440	1,975 Added 80.91%	4,416 $239,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $6,399 - $7,636	-132 Reduced 5.13%	2,441 $125,000
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $5,152 - $5,760	-89 Reduced 3.34%	2,573 $149,000
Q2 2023 Aug 02, 2023	BUY	$63.71 - $70.74 $2,484 - $2,758	39 Added 1.49%	2,662 $170,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $1,248 - $1,416	19 Added 0.73%	2,623 $181,000
Q4 2022 Feb 01, 2023	SELL	$68.48 - $81.09 $3,355 - $3,973	-49 Reduced 1.85%	2,604 $187,000
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $25 - $14,983	195 Added 7.93%	2,653 $189,000
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $12,563 - $13,836	173 Added 7.57%	2,458 $189,000
Q1 2022 May 04, 2022	SELL	$61.48 - $73.72 $29,387 - $35,238	-478 Reduced 17.3%	2,285 $167,000
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $911 - $1,062	17 Added 0.62%	2,763 $172,000
Q3 2021 Nov 02, 2021	SELL	$59.17 - $69.31 $13,904 - $16,287	-235 Reduced 7.88%	2,746 $162,000
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $990 - $1,078	16 Added 0.54%	2,981 $199,000
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $890 - $1,001	15 Added 0.51%	2,965 $187,000
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $923 - $1,046	16 Added 0.55%	2,950 $183,000
Q3 2020 Oct 27, 2020	BUY	$57.43 - $63.64 $918 - $1,018	16 Added 0.55%	2,934 $177,000
Q2 2020 Jul 30, 2020	BUY	$54.82 - $64.09 $45,007 - $52,617	821 Added 39.15%	2,918 $172,000
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $97,300 - $141,400	2,097 New	2,097 $117,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $118,486 - $153,648	-2,430 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$55.19 - $62.25 $827 - $933	15 Added 0.62%	2,430 $151,000
Q2 2018 Jul 25, 2018	BUY	$50.53 - $62.98 $808 - $1,007	16 Added 0.67%	2,415 $134,000
Q1 2018 Apr 25, 2018	BUY	$59.92 - $68.98 $12,822 - $14,761	214 Added 9.79%	2,399 $152,000
Q4 2017 Jan 31, 2018	BUY	$59.94 - $65.35 $839 - $914	14 Added 0.64%	2,185 $134,000
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $828 - $956	15 Added 0.7%	2,171 $138,000
Q2 2017 Aug 07, 2017	BUY	N/A	2,156	2,156 $120,000

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Chip Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Chip Partners, Inc. with notifications on news.

Account

Blue Chip Partners, Inc. Bristol Myers Squibb CO Transaction History